Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme.
暂无分享,去创建一个
Ronald N. Jones | M. Toleman | T. Walsh | A. Gales | A. Simm | Ronald N Jones | D. Biedenbach | Ana C Gales | Mark A Toleman | Timothy R Walsh | Alan M Simm | Tanya A Murphy | Doug J Biedenbach
[1] M. Mulvey,et al. Complete Nucleotide Sequence of a 43-Kilobase Genomic Island Associated with the Multidrug Resistance Region of Salmonella enterica Serovar Typhimurium DT104 and Its Identification in Phage Type DT120 and Serovar Agona , 2001, Journal of bacteriology.
[2] Timothy R. Walsh,et al. Sequence analysis of the L1 metallo-β-lactamase from Xanthomonas maltophilia , 1994 .
[3] S. Gamblin,et al. Enzyme kinetics and biochemical analysis of ImiS, the metallo-beta-lactamase from Aeromonas sobria 163a. , 1996, The Journal of antimicrobial chemotherapy.
[4] M. Page. Understanding metallo β-lactamases , 2002 .
[5] J. Frère,et al. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile. , 1998, The Biochemical journal.
[6] Richard A. Moore,et al. Nosocomial Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa with a New blaIMP Allele, blaIMP-7 , 2002, Antimicrobial Agents and Chemotherapy.
[7] A P MacGowan,et al. Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia , 1997, Antimicrobial agents and chemotherapy.
[8] R. Pridmore. New and versatile cloning vectors with kanamycin-resistance marker. , 1987, Gene.
[9] J. Frère,et al. Purification and Biochemical Characterization of the VIM-1 Metallo-β-Lactamase , 2000, Antimicrobial Agents and Chemotherapy.
[10] Y. Arakawa,et al. A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP , 1995, Antimicrobial agents and chemotherapy.
[11] R M Hall,et al. Site‐specific insertion of genes into integrons: role of the 59‐base element and determination of the recombination cross‐over point , 1991, Molecular microbiology.
[12] J. Frère,et al. Biochemical Characterization of the Pseudomonas aeruginosa 101/1477 Metallo-β-Lactamase IMP-1 Produced byEscherichia coli , 1999, Antimicrobial Agents and Chemotherapy.
[13] O. Massidda,et al. The Aeromonas hydrophila cphA gene: molecular heterogeneity among class B metallo-beta-lactamases , 1991, Journal of bacteriology.
[14] A. Bolmström,et al. Evaluation of a New Etest for Detecting Metallo-β-Lactamases in Routine Clinical Testing , 2002, Journal of Clinical Microbiology.
[15] S. Ichiyama,et al. PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams , 1996, Journal of clinical microbiology.
[16] N. Woodford,et al. IMP-4, a Novel Metallo-β-Lactamase from Nosocomial Acinetobacter spp. Collected in Hong Kong between 1994 and 1998 , 2001, Antimicrobial Agents and Chemotherapy.
[17] G. Cornaglia,et al. Cloning and Characterization of blaVIM, a New Integron-Borne Metallo-β-Lactamase Gene from a Pseudomonas aeruginosa Clinical Isolate , 1999, Antimicrobial Agents and Chemotherapy.
[18] M. Hussain,et al. Cloning and sequencing of the metallothioprotein beta-lactamase II gene of Bacillus cereus 569/H in Escherichia coli , 1985, Journal of bacteriology.
[19] N. Woodford,et al. Carbapenemases: a problem in waiting? , 2000, Current opinion in microbiology.
[20] F. Yoshimura,et al. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance , 1994, Antimicrobial Agents and Chemotherapy.
[21] N. Woodford,et al. Outbreak of Infections Caused by Pseudomonas aeruginosa Producing VIM-1 Carbapenemase in Greece , 2000, Journal of Clinical Microbiology.
[22] Thierry Naas,et al. Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in France , 2000, Antimicrobial Agents and Chemotherapy.
[23] A. MacGowan,et al. Nucleotide and Amino Acid Sequences of the Metallo-β-Lactamase, ImiS, from Aeromonas veronii bv. sobria , 1998, Antimicrobial Agents and Chemotherapy.
[24] M. Malamy,et al. Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus beta-lactamase II , 1990, Journal of bacteriology.
[25] N. Woodford,et al. Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from Singapore , 1999, The Lancet.
[26] J. Birnbaum,et al. MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities , 1980, Antimicrobial Agents and Chemotherapy.
[27] Y. Arakawa,et al. Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens , 1995, Antimicrobial agents and chemotherapy.